Primary Neuroendocrine Carcinoma of the Liver: Difficult Diagnosis of a Rare Neoplasm

References

• Ali M., Fayemi A. O., Braun E. V. Malignant Apudoma of the liver with symptomatic intractable hypoglycemia. Cancer, 1978, 142: 686-92.
   Web of Science ®Google Scholar
• Gould V. E., Banner B. F., Baerwaldt M. Neuroendocrine neoplasms in unusual primary sites. Diagn Histopathol, 1981, 4: 263-77.
   PubMedGoogle Scholar
• Yu-Ping X., Ji-yao Y. Primary neuroendocrine carcinoma of the liver. Ultrastruct Pathol, 1986, 10: 331-6.
   PubMed Web of Science ®Google Scholar
• Andreola S., Lombardi L., Audisio R. A. et al. A clinicopathologic study of primary hepatic carcinoid tumors. Cancer, 1990, 65: 1211-18.
   PubMed Web of Science ®Google Scholar
• Larriva-Sahd J., Angeles-Angeles A., Hernandez-Pando R. et al. Ultrastructural and immunocytochemical study of a primary gastrinoma of the liver. Ultrastruct Pathol, 1992, 16: 667-72.
   PubMed Web of Science ®Google Scholar
• Hsueh C., Tan X. D., Gonzales-Crussi F. Primary hepatic neuroendocrine carcinoma in a child. Cancer, 1993, 71: 2660-5.
   PubMed Web of Science ®Google Scholar
• Wee A., Nilsson B., Yap I. Fine needle aspiration biopsy of small/intermediate cell tumors in the liver. Acta Cytol, 1996, 40: 937-47.
   PubMed Web of Science ®Google Scholar
• Miura K., Shirasawa H. Primary carcinoid tumor of the liver. Am J Clin Pathol, 1988, 89: 561-4.
   PubMed Web of Science ®Google Scholar
• Tsuchimochi S., Nakajo M., Inoue H. et al. Primary hepatic neuroendocrine carcinoma with multiple metastases: a case report. Radiat Med, 1997, 13: 183-5.
   Google Scholar
• Lundstedt C., Linjawi T., Amin T. Liver VIPoma: report of two cases and literature review. Abdom Imaging, 1994, 19: 433-7.
   PubMedGoogle Scholar
• Papadogiannakis N., Gad A., Sjostedt S. et al. Adenocarcinoid of the liver arising within an area of hamartoma with predominant bile duct component. J Clin Gastroenterol, 1996, 23: 145-51.
   PubMed Web of Science ®Google Scholar
• Primack A., Wilson J., O’Connor G. T. et al. Hepatocellular carcinoma with the carcinoid syndrome. Cancer, 1971, 27: 1182-9.
   PubMed Web of Science ®Google Scholar
• Johnson F. D. Ectopic ACTH svndrome in APUD tumors. Oncology, 1982, 39: 358-61.
   PubMed Web of Science ®Google Scholar
• Rosch T., Lightdale C. J., Botet J. F. et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med, 1992, 326: 1721-6.
   PubMed Web of Science ®Google Scholar
• Modlin I. M., Tang L. H. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology, 1997, 112: 583-90.
   PubMed Web of Science ®Google Scholar
• Gibril F., Reynolds J. C., Doppman J. L. et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med, 1996, 125: 26-34.
   PubMed Web of Science ®Google Scholar
• Cadiot G., Lebtahi R., Sarda L. et al. Preoperative detection of duodenal gastrinomas and peripancreatic lymphnodes by somatostatin receptor scintigraphy. Gastroenterology, 1996, 111: 845-54.
   PubMed Web of Science ®Google Scholar
• Ihse L, Persson B., Tibblin S. Neuroendocrine metastases of the liver. World J Surg, 1995, 19: 76-82.
   PubMed Web of Science ®Google Scholar
• Que F. G., Nagorney D. M., Batts K. P. et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg, 1995, 169: 36-43.
   PubMed Web of Science ®Google Scholar
• Anthuber M., Jauch K. W., Briegel J. et al. Results of liver transplantation for gastroenteropancrcatic tumor metastases. World J Surg, 1996, 20: 73-6.
   PubMed Web of Science ®Google Scholar
• Curtiss S. I., Mor E., Schwartz M. E. et al. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg, 1995, 180: 184-7.
   PubMed Web of Science ®Google Scholar
• Jacobsen M. B., Hanssen L. E. Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial. J Intern Med, 1995, 237: 269-75.
   PubMed Web of Science ®Google Scholar
• Di Bartolomeo M., Bajetta E., Buzzoni R. et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. Cancer, 1996, 77: 402-8.
   PubMed Web of Science ®Google Scholar
• Anthony L. B., Martin W., Delbeke D. et al. Somatostatin receptor imaging: predictive and prognostic considerations. Digestion, 1996, 57: 50-3.
   PubMed Web of Science ®Google Scholar
• Perry L. J., Stuart K., Stokes K. R. et al. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery, 1994. 116: 1111-16.
   PubMed Web of Science ®Google Scholar